Dual-action formula for powerful results

Helps break through weight plateaus

Improves glucose and energy balance

Mounjaro®

  • In Stock

| Weight loss

A once-weekly GLP-1/GIP injection that helps regulate appetite, reduce cravings, and support meaningful weight loss. Originally developed for type 2 diabetes, Mounjaro® is now widely prescribed for weight management due to its powerful dual-action formula.

Once-weekly injection in pre-measured auroinjector pens

Easily upload your valid prescription for fast processing.

Ships directly to your door in 5–7 business days after prescription verification.

Upload your prescription today

Mounjaro Kwikpen

Tirzepatide

Select product strength & quantity:
Select product strength & quantity:
Select product strength & quantity:
Select product strength & quantity:
Select product strength & quantity:
Select product strength & quantity:
$500.00
A once-weekly GLP-1/GIP injection that helps regulate appetite, reduce cravings, and support meaningful weight loss. Originally developed for type 2 diabetes, Mounjaro® is now widely prescribed for weight management due to its powerful dual-action formula.

Based on clinical research evaluating GLP-1 medications for chronic weight management.

This chart is for general illustration purposes only. Actual results vary and no specific outcome is guaranteed. Always consult your healthcare provider for personalized medical advice. Sources: STEP Trials, SURMOUNT-1, SURPASS-1, FDA Prescribing Information.

Weight Loss Patterns:

Sustainable GLP-1 Therapy vs. Yo-Yo Dieting

Many diets promise quick fixes but often lead to weight regain over time.

GLP-1 medications offer a different approach, working with your biology to support steady, consistent weight loss.

The chart below illustrates how medical therapy may help create sustainable progress compared to the repeated ups and downs of yo-yo dieting.

typical dosing schedule

Please consult your doctor for exact instructions. this is a general example of a typical titration schedule

Ozempic®

Weeks

Dose

Weeks 1 – 4
0.25mg / week
Weeks 5 – 8
0.5mg / week

Common Dose

Weeks 9 +
1 mg / day

Wegovy®

Weeks

Dose

Weeks 1 – 4
0.25mg / week
Weeks 5 – 8
0.5mg / week
Weeks 9 – 11
1 mg / week
Weeks 13 – 16
1.7 mg / week

Common Dose

Weeks 17 +
2.4 mg / day

Mounjaro®

Weeks

Dose

Weeks 1 – 4
2.5 mg / week
Weeks 5 – 8
5 mg / week

Common Dose

Weeks 9 – 12
7.5 mg / day
Weeks 13 – 16
10 mg / day
Weeks 17 – 20
12.5 mg / day
Weeks 21+
15 mg / day

Trusted Weight Loss, Made Simple.

Upload your GLP-1 prescription and get top brands like Ozempic® or Wegovy® delivered in days—no doctor visits or pharmacy lines.

Compare GLP-1 Medications

Feature

Wegovy

Ozempic®

Mounjaro®

Primary Use

Weight loss

Type 2 diabetes (commonly used for weight loss)

Type 2 diabetes (commonly used for weight loss)

Active Ingredient

Semaglutide

Semaglutide

Tirzepatide

Dosing Frequency

Once weekly

Once weekly

Once weekly

How It Works

Helps regulate appetite and reduce food intake

Reduces appetite and helps you feel full longer

Dual-action: controls appetite and cravings

FDA Approval Status

Yes

Same active ingredient as Wegovy®; often used for weight management under physician guidance

Approved for diabetes; commonly prescribed off-label for weight management

Key Highlights

Higher-dose semaglutide, approved for weight loss

Same ingredient as Wegovy®, lower dose

Approved for diabetes; commonly prescribed off-label for weight management

Best For

Those focused on weight management

Those seeking appetite control and steady results

Those looking for potentially faster results

Compare GLP-1 Medications

Feature

Wegovy

Primary Use

Weight loss

Active Ingredient

Semaglutide

Dosing Frequency

Once weekly

How It Works

Helps regulate appetite and reduce food intake

FDA Approval Status

Yes

Key Highlights

Higher-dose semaglutide, approved for weight loss

Best For

Those focused on weight management

Compare GLP-1 Medications

Feature

Ozempic®

Primary Use

Type 2 diabetes (commonly used for weight loss)

Active Ingredient

Semaglutide

Dosing Frequency

Once weekly

How It Works

Reduces appetite and helps you feel full longer

FDA Approval Status

Same active ingredient as Wegovy®; often used for weight management under physician guidance

Key Highlights

Same ingredient as Wegovy®, lower dose

Best For

Those seeking appetite control and steady results

Compare GLP-1 Medications

Feature

Mounjaro®

Primary Use

Type 2 diabetes (commonly used for weight loss)

Active Ingredient

Tirzepatide

Dosing Frequency

Once weekly

How It Works

Dual-action: controls appetite and cravings

FDA Approval Status

Approved for diabetes; commonly prescribed off-label for weight management

Key Highlights

Approved for diabetes; commonly prescribed off-label for weight management

Best For

Those looking for potentially faster results